Home/Filings/4/0000950170-25-088602
4//SEC Filing

KAPLAN GILLA 4

Accession 0000950170-25-088602

CIK 0001863127other

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 5:42 PM ET

Size

6.2 KB

Accession

0000950170-25-088602

Insider Transaction Report

Form 4
Period: 2025-06-17
KAPLAN GILLA
Director
Transactions
  • Sale

    Common Stock

    2025-06-17$10.35/sh10$10437,799 total
  • Sale

    Common Stock

    2025-06-18$9.78/sh9,568$93,59628,231 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.55 to $9.93. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Documents

1 file

Issuer

Tyra Biosciences, Inc.

CIK 0001863127

Entity typeother

Related Parties

1
  • filerCIK 0001247024

Filing Metadata

Form type
4
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 5:42 PM ET
Size
6.2 KB